PMC:7219429 / 2027-2368
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T17 | 40-55 | Body_part | denotes | plasma membrane | http://purl.org/sig/ont/fma/fma63841 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 237-245 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T23 | 40-46 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T24 | 47-55 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T40 | 13-22 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T41 | 196-199 | Chemical | denotes | ATM | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 126-246 | Sentence | denotes | This molecular mechanism may explain the beneficial effects of CLQ-OH/ATM combination therapy in patients with COVID-19. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 69 | 223-231 | Species | denotes | patients | Tax:9606 |
| 82 | 189-195 | Chemical | denotes | CLQ-OH | |
| 83 | 196-199 | Chemical | denotes | ATM | MESH:D017963 |
| 87 | 237-245 | Disease | denotes | COVID-19 | MESH:C000657245 |